Volgen
Frederico Sallum
Frederico Sallum
Edwards Lifesciences
Geverifieerd e-mailadres voor edwards.com
Titel
Geciteerd door
Geciteerd door
Jaar
A DEMATEL-TOPSIS-WINGS approach to the classification of multimarket investment funds
FSV Sallum, LFAM Gomes, MAS Machado
Independent Journal of Management & Production 9 (4), 1203-1234, 2018
122018
A multicriteria approach to the prioritisation of stock investment funds
FSV Sallum, LFAM Gomes, MAS Machado
International Journal of Business and Systems Research 13 (1), 120-134, 2019
92019
Investments in a new Technological Infrastructure: decision making using the ELECTRE-TRI methodology
JGD Neto, MAS Machado, LFAM Gomes, AM Caldeira, FSV Sallum
Procedia computer science 122, 194-199, 2017
52017
PRO41 A multi-criteria decision analysis contribution to the Canadian intravenous immunoglobulin cost-effectiveness analysis
F Sallum, G Marasco, E Asano, L Fahham, LM Amaral, C Pepe
Value in Health 23, S336, 2020
32020
A multi-criteria support for the cost-effectiveness analysis of health interventions
FSV Sallum
Brazilian Journal of Health Review 3 (6), 17167-17182, 2020
32020
PMU13 A multi-criteria approach to the study of chronic non-communicable diseases in Brazil
FSV Sallum, LM Amaral, RA Fernandes
Value in Health Regional Issues 19, S58, 2019
32019
A multi-criteria support for the cost-effectiveness analysis of health interventions
FSV Sallum
3*
The TODIM multi-criteria method applied to the ANBIMA ranking of Brazilian investment funds
FSV Sallum, LFAM Gomes, MAS Machado
International Journal of Business and Systems Research 14 (1), 56-73, 2020
22020
PMU12 A non-communicable diseases multi-criteria analysis in Latin America
FSV Sallum, EW Aguiar, L Lins, A Pontes, LM Amaral, RA Fernandes
Value in Health Regional Issues 19, S57-S58, 2019
22019
HTA16 An MCDA approach to identify direct relationships between health states in Markov chains for heart failure treatments
F Sallum
Value in Health 25 (7), S506-S507, 2022
12022
EE439 An MCDA preference index support for the ICUR analysis between psoriatic arthritis treatments
F Sallum
Value in Health 25 (7), S421, 2022
12022
Uma contribuição MCDA para a análise de custo-efetividade de tecnologias para evitar o tromboembolismo venoso em pacientes submetidos à artroplastia total de quadril sob a …
FSV Sallum, AFS de Brito
JORNAL DE ASSISTÊNCIA FARMACÊUTICA E FARMACOECONOMIA 7 (s. 1), 2022
12022
A novel proposal to use the WINGS method in a multi-criteria context
FSV Sallum, LFAM Gomes, J Michnik
International Journal of Applied Management Science 14 (4), 281-298, 2022
12022
A hybrid approach to apply DEMATEL in a multi-criteria setting
FSV Sallum, LFAM Gomes, MAS Machado, LSV Sallum
Independent Journal of Management & Production 11 (1), 194-207, 2020
12020
A fuzzy system to stimulate the planting of beans in Brazil
FSV Sallum, LFAM Gomes, MAS Machado
Independent Journal of Management & Production 9 (2), 375-394, 2018
12018
Uma abordagem MCDA para identificar lacunas e perspectivas sobre o tratamento de asma no Brasil
FSV Sallum, WA Oliveira, MF Penha, FG de Menezes
Jornal de Assistência Farmacêutica e Farmacoeconomia 9 (2), 2024
2024
Uma abordagem MCDA para identificar relações-chave entre estados de saúde de esclerose múltipla
FSV Sallum
Jornal de Assistência Farmacêutica e Farmacoeconomia 8 (4), 2023
2023
RWD132 A Real-World Evidence Study on the Chronic Obstructive Pulmonary Disease Treatments Submitted to the Brazilian National Committee for Health Technology Incorporation
F Menezes, F Sallum, WA Oliveira
Value in Health 26 (6), S386, 2023
2023
HPR11 Multicriteria Decision Analysis (MCDA) to Identify Criteria for Guiding Decision Making for Post-Menopausal Osteoporosis Treatment in the Brazilian Public Healthcare System
L Mensor, MP Rosim, T Marchesan, D Rigo, F Sallum, LM Amaral
Value in Health 25 (7), S468, 2022
2022
Lacunas e perspectivas do tratamento da asma no Brasil: uma análise sobre o perfil de tratamentos submetidos à incorporação no sistema de saúde público brasileiro
FG de Menezes, F Sallum, MF Penha, WA Oliveira
JORNAL DE ASSISTÊNCIA FARMACÊUTICA E FARMACOECONOMIA 7 (s. 1), 2022
2022
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20